FWM
GILD icon

Focused Wealth Management’s Gilead Sciences GILD Stock Holding History

Focused Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,600
Closed -$23K – 693
2018
Q1 		$23K Hold
1,600
– – 0.01% 371
2017
Q4 		$15K Buy
+1,600
New +$122K ﹤0.01% 409

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Focused Wealth Management's GILD Position: Q2 2026 in Review

Focused Wealth Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,784 shares worth $225K. The stake represents 0.02% of the portfolio and ranks #221 among its holdings. This is a return to the name: Focused Wealth Management previously reported a position in GILD as recently as Q4 2023.

Focused Wealth Management first reported a position in GILD in Q2 2014 and has held it in 40 quarters since. The position peaked at $2.02M in Q3 2017. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Focused Wealth Management held 1,784 shares of Gilead Sciences worth $225K as of Q2 2026.
  • Gilead Sciences was a new Focused Wealth Management position in Q2 2026.
  • Gilead Sciences made up 0.02% of Focused Wealth Management's portfolio in Q2 2026, its #221 holding.
  • Focused Wealth Management first reported a position in Gilead Sciences in Q2 2014 and has held it in 40 quarters since.
  • Focused Wealth Management's Gilead Sciences position peaked at $2.02M in Q3 2017.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Focused Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.